nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—Cytarabine—Gemcitabine—urinary bladder cancer	0.145	0.513	CrCrCtD
Fludarabine—Azacitidine—Gemcitabine—urinary bladder cancer	0.137	0.487	CrCrCtD
Fludarabine—RRM1—Gemcitabine—urinary bladder cancer	0.119	0.231	CbGbCtD
Fludarabine—SLC28A3—Gemcitabine—urinary bladder cancer	0.103	0.2	CbGbCtD
Fludarabine—POLA1—Gemcitabine—urinary bladder cancer	0.103	0.2	CbGbCtD
Fludarabine—SLC29A1—Gemcitabine—urinary bladder cancer	0.0683	0.133	CbGbCtD
Fludarabine—DCK—Gemcitabine—urinary bladder cancer	0.0633	0.123	CbGbCtD
Fludarabine—SLC29A1—Fluorouracil—urinary bladder cancer	0.0584	0.114	CbGbCtD
Fludarabine—SLC28A3—prostate gland—urinary bladder cancer	0.00321	0.104	CbGeAlD
Fludarabine—POLA1—prostate gland—urinary bladder cancer	0.00225	0.0729	CbGeAlD
Fludarabine—POLA1—seminal vesicle—urinary bladder cancer	0.00191	0.0617	CbGeAlD
Fludarabine—RRM1—prostate gland—urinary bladder cancer	0.00179	0.0579	CbGeAlD
Fludarabine—RRM1—seminal vesicle—urinary bladder cancer	0.00151	0.049	CbGeAlD
Fludarabine—POLA1—urethra—urinary bladder cancer	0.00151	0.0488	CbGeAlD
Fludarabine—SLC29A1—prostate gland—urinary bladder cancer	0.00145	0.0471	CbGeAlD
Fludarabine—DCK—prostate gland—urinary bladder cancer	0.00139	0.045	CbGeAlD
Fludarabine—RRM1—smooth muscle tissue—urinary bladder cancer	0.00127	0.041	CbGeAlD
Fludarabine—RRM1—renal system—urinary bladder cancer	0.00122	0.0395	CbGeAlD
Fludarabine—Cytarabine—POLB—urinary bladder cancer	0.00121	0.326	CrCbGaD
Fludarabine—RRM1—urethra—urinary bladder cancer	0.0012	0.0388	CbGeAlD
Fludarabine—DCK—seminal vesicle—urinary bladder cancer	0.00118	0.038	CbGeAlD
Fludarabine—POLA1—vagina—urinary bladder cancer	0.00111	0.036	CbGeAlD
Fludarabine—SLC29A1—renal system—urinary bladder cancer	0.000991	0.0321	CbGeAlD
Fludarabine—RRM1—female reproductive system—urinary bladder cancer	0.000976	0.0316	CbGeAlD
Fludarabine—SLC29A1—urethra—urinary bladder cancer	0.000974	0.0315	CbGeAlD
Fludarabine—DCK—urethra—urinary bladder cancer	0.00093	0.0301	CbGeAlD
Fludarabine—RRM1—vagina—urinary bladder cancer	0.000883	0.0286	CbGeAlD
Fludarabine—SLC29A1—female reproductive system—urinary bladder cancer	0.000794	0.0257	CbGeAlD
Fludarabine—Clofarabine—RRM2—urinary bladder cancer	0.00077	0.208	CrCbGaD
Fludarabine—DCK—female reproductive system—urinary bladder cancer	0.000758	0.0245	CbGeAlD
Fludarabine—POLA1—lymph node—urinary bladder cancer	0.00072	0.0233	CbGeAlD
Fludarabine—SLC29A1—vagina—urinary bladder cancer	0.000718	0.0232	CbGeAlD
Fludarabine—DCK—vagina—urinary bladder cancer	0.000686	0.0222	CbGeAlD
Fludarabine—DCK—Doxorubicin—Valrubicin—urinary bladder cancer	0.000659	0.292	CbGdCrCtD
Fludarabine—DCK—Epirubicin—Valrubicin—urinary bladder cancer	0.000659	0.292	CbGdCrCtD
Fludarabine—Flavin adenine dinucleotide—POR—urinary bladder cancer	0.000655	0.177	CrCbGaD
Fludarabine—SLC28A3—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000581	0.00858	CbGpPWpGaD
Fludarabine—POLA1—Inhibition of replication initiation of damaged DNA by RB1/E2F1—RB1—urinary bladder cancer	0.00058	0.00856	CbGpPWpGaD
Fludarabine—DCK—Nucleotide metabolism—TYMP—urinary bladder cancer	0.000579	0.00854	CbGpPWpGaD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—ERCC2—urinary bladder cancer	0.000575	0.00849	CbGpPWpGaD
Fludarabine—RRM1—lymph node—urinary bladder cancer	0.000571	0.0185	CbGeAlD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—MTHFR—urinary bladder cancer	0.00054	0.00798	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—RRM2—urinary bladder cancer	0.000538	0.00794	CbGpPWpGaD
Fludarabine—RRM1—Azacitidine—Gemcitabine—urinary bladder cancer	0.000497	0.221	CbGdCrCtD
Fludarabine—DCK—Purine metabolism—GPX1—urinary bladder cancer	0.000492	0.00727	CbGpPWpGaD
Fludarabine—SLC29A1—lymph node—urinary bladder cancer	0.000464	0.015	CbGeAlD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—SMC1A—urinary bladder cancer	0.000457	0.00675	CbGpPWpGaD
Fludarabine—DCK—Nucleotide metabolism—RRM2—urinary bladder cancer	0.000452	0.00667	CbGpPWpGaD
Fludarabine—DCK—lymph node—urinary bladder cancer	0.000444	0.0144	CbGeAlD
Fludarabine—Cladribine—RRM2—urinary bladder cancer	0.000442	0.119	CrCbGaD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000433	0.0064	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—RRM2—urinary bladder cancer	0.000414	0.00611	CbGpPWpGaD
Fludarabine—POLA1—Telomere Maintenance—LIG1—urinary bladder cancer	0.000401	0.00593	CbGpPWpGaD
Fludarabine—POLA1—E2F mediated regulation of DNA replication—CCNE1—urinary bladder cancer	0.000388	0.00573	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—XRCC1—urinary bladder cancer	0.000387	0.00572	CbGpPWpGaD
Fludarabine—POLA1—E2F mediated regulation of DNA replication—TYMS—urinary bladder cancer	0.000381	0.00562	CbGpPWpGaD
Fludarabine—Flavin adenine dinucleotide—NQO1—urinary bladder cancer	0.000376	0.102	CrCbGaD
Fludarabine—POLA1—Extension of Telomeres—TERT—urinary bladder cancer	0.000368	0.00543	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—CCNE1—urinary bladder cancer	0.000365	0.00539	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—TYMS—urinary bladder cancer	0.000358	0.00529	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—SMC1A—urinary bladder cancer	0.000352	0.0052	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—RRM2—urinary bladder cancer	0.000349	0.00515	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000348	0.00514	CbGpPWpGaD
Fludarabine—POLA1—Synthesis of DNA—LIG1—urinary bladder cancer	0.00034	0.00502	CbGpPWpGaD
Fludarabine—RRM1—Nucleotide metabolism—TYMS—urinary bladder cancer	0.00034	0.00502	CbGpPWpGaD
Fludarabine—POLA1—Chromosome Maintenance—LIG1—urinary bladder cancer	0.000334	0.00494	CbGpPWpGaD
Fludarabine—RRM1—Nucleotide metabolism—GPX1—urinary bladder cancer	0.000322	0.00475	CbGpPWpGaD
Fludarabine—POLA1—DNA Replication—LIG1—urinary bladder cancer	0.000319	0.00471	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—CCNE1—urinary bladder cancer	0.000317	0.00468	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—TYMS—urinary bladder cancer	0.000311	0.0046	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—RRM2—urinary bladder cancer	0.000303	0.00447	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—PLAU—urinary bladder cancer	0.000296	0.00436	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000295	0.00436	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—ATM—urinary bladder cancer	0.00028	0.00414	CbGpPWpGaD
Fludarabine—POLA1—S Phase—LIG1—urinary bladder cancer	0.000279	0.00412	CbGpPWpGaD
Fludarabine—POLA1—S Phase—STAG2—urinary bladder cancer	0.000279	0.00412	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000266	0.00392	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000264	0.0039	CbGpPWpGaD
Fludarabine—DCK—Nucleotide metabolism—TYMS—urinary bladder cancer	0.000261	0.00386	CbGpPWpGaD
Fludarabine—POLA1—E2F mediated regulation of DNA replication—RB1—urinary bladder cancer	0.000258	0.00381	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—SMC1A—urinary bladder cancer	0.000258	0.0038	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—RRM2—urinary bladder cancer	0.000253	0.00373	CbGpPWpGaD
Fludarabine—Adenosine monophosphate—SRC—urinary bladder cancer	0.000253	0.0683	CrCbGaD
Fludarabine—DCK—Nucleotide metabolism—GPX1—urinary bladder cancer	0.000247	0.00365	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CCNE1—urinary bladder cancer	0.000244	0.0036	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—CREBBP—urinary bladder cancer	0.000244	0.0036	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—RB1—urinary bladder cancer	0.000243	0.00359	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—CDK4—urinary bladder cancer	0.000243	0.00358	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—TYMS—urinary bladder cancer	0.00024	0.00354	CbGpPWpGaD
Fludarabine—DCK—Doxorubicin—Epirubicin—urinary bladder cancer	0.000229	0.102	CbGdCrCtD
Fludarabine—RRM1—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.000224	0.00331	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00022	0.00325	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—SMC1B—urinary bladder cancer	0.000219	0.00323	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—CDKN2A—urinary bladder cancer	0.000213	0.00315	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000213	0.00315	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—RRM2—urinary bladder cancer	0.000213	0.00315	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000212	0.00314	CbGpPWpGaD
Fludarabine—DCK—Epirubicin—Doxorubicin—urinary bladder cancer	0.000212	0.094	CbGdCrCtD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—RB1—urinary bladder cancer	0.000211	0.00312	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—CCNE1—urinary bladder cancer	0.000205	0.00303	CbGpPWpGaD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.000205	0.00303	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—TYMS—urinary bladder cancer	0.000202	0.00298	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000196	0.0029	CbGpPWpGaD
Fludarabine—POLA1—S Phase—SMC1A—urinary bladder cancer	0.000195	0.00288	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CDK4—urinary bladder cancer	0.000187	0.00276	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CCNE1—urinary bladder cancer	0.000179	0.00264	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—TYMS—urinary bladder cancer	0.000175	0.00259	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—CDKN1A—urinary bladder cancer	0.000174	0.00258	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000174	0.00257	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000169	0.00249	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—ESPL1—urinary bladder cancer	0.000167	0.00247	CbGpPWpGaD
Fludarabine—POLA1—Telomere Maintenance—TERT—urinary bladder cancer	0.000167	0.00246	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—PLAU—urinary bladder cancer	0.000166	0.00246	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—EP300—urinary bladder cancer	0.000166	0.00245	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000166	0.00245	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—RB1—urinary bladder cancer	0.000162	0.0024	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000159	0.00235	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—ATM—urinary bladder cancer	0.000158	0.00233	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—CCND1—urinary bladder cancer	0.000157	0.00231	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—CDKN1A—urinary bladder cancer	0.000152	0.00224	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.00015	0.00221	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—CCNE1—urinary bladder cancer	0.000149	0.0022	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000149	0.00219	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000147	0.00217	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—TYMS—urinary bladder cancer	0.000146	0.00216	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—MYC—urinary bladder cancer	0.000145	0.00214	CbGpPWpGaD
Fludarabine—POLA1—Chromosome Maintenance—TERT—urinary bladder cancer	0.000139	0.00205	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—CREBBP—urinary bladder cancer	0.000137	0.00203	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—RB1—urinary bladder cancer	0.000137	0.00202	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CDK4—urinary bladder cancer	0.000137	0.00202	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CCNE1—urinary bladder cancer	0.000135	0.002	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.00013	0.00192	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.00013	0.00192	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000129	0.00191	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.000129	0.0019	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—STAG2—urinary bladder cancer	0.000127	0.00187	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—urinary bladder cancer	0.000126	0.00186	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CCNE1—urinary bladder cancer	0.000126	0.00185	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—ESPL1—urinary bladder cancer	0.000125	0.00185	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—TYMS—urinary bladder cancer	0.000123	0.00182	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—urinary bladder cancer	0.000121	0.00178	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—CDKN2A—urinary bladder cancer	0.00012	0.00178	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.00012	0.00177	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTZ1—urinary bladder cancer	0.000119	0.00176	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—RB1—urinary bladder cancer	0.000119	0.00176	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000118	0.00174	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—urinary bladder cancer	0.000117	0.00172	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000113	0.00167	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTO2—urinary bladder cancer	0.000113	0.00166	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NAT1—urinary bladder cancer	0.000113	0.00166	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—ESPL1—urinary bladder cancer	0.000112	0.00165	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000112	0.00165	CbGpPWpGaD
Fludarabine—POLA1—Synthesis of DNA—RB1—urinary bladder cancer	0.00011	0.00162	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CDK4—urinary bladder cancer	0.000104	0.00153	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—urinary bladder cancer	0.000103	0.00152	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—UGT2B7—urinary bladder cancer	0.000103	0.00152	CbGpPWpGaD
Fludarabine—POLA1—DNA Replication—RB1—urinary bladder cancer	0.000103	0.00152	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—RB1—urinary bladder cancer	9.93e-05	0.00147	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—CDKN1A—urinary bladder cancer	9.83e-05	0.00145	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—urinary bladder cancer	9.67e-05	0.00143	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDK4—urinary bladder cancer	9.62e-05	0.00142	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	9.52e-05	0.00141	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—LIG1—urinary bladder cancer	9.49e-05	0.0014	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—STAG2—urinary bladder cancer	9.49e-05	0.0014	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	9.46e-05	0.0014	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—EP300—urinary bladder cancer	9.35e-05	0.00138	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	9.35e-05	0.00138	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP4B1—urinary bladder cancer	9.28e-05	0.00137	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	9.25e-05	0.00137	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTZ1—urinary bladder cancer	9.15e-05	0.00135	CbGpPWpGaD
Fludarabine—POLA1—S Phase—RB1—urinary bladder cancer	9.01e-05	0.00133	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—SMC1A—urinary bladder cancer	8.89e-05	0.00131	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—urinary bladder cancer	8.83e-05	0.0013	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SLC19A1—urinary bladder cancer	8.77e-05	0.00129	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.76e-05	0.00129	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NAT1—urinary bladder cancer	8.67e-05	0.00128	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTO2—urinary bladder cancer	8.67e-05	0.00128	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PRSS3—urinary bladder cancer	8.54e-05	0.00126	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—urinary bladder cancer	8.54e-05	0.00126	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—STAG2—urinary bladder cancer	8.49e-05	0.00125	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—LIG1—urinary bladder cancer	8.49e-05	0.00125	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—RB1—urinary bladder cancer	8.36e-05	0.00124	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	8.36e-05	0.00123	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	8.28e-05	0.00122	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—MYC—urinary bladder cancer	8.15e-05	0.0012	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	8.08e-05	0.00119	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	8.06e-05	0.00119	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—urinary bladder cancer	7.95e-05	0.00117	CbGpPWpGaD
Fludarabine—DCK—Metabolism—UGT2B7—urinary bladder cancer	7.93e-05	0.00117	CbGpPWpGaD
Fludarabine—POLA1—Synthesis of DNA—CDKN1A—urinary bladder cancer	7.89e-05	0.00117	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—RRM2—urinary bladder cancer	7.82e-05	0.00115	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	7.69e-05	0.00114	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	7.48e-05	0.0011	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	7.46e-05	0.000752	CcSEcCtD
Fludarabine—Infection—Etoposide—urinary bladder cancer	7.46e-05	0.000752	CcSEcCtD
Fludarabine—POLA1—DNA Replication—CDKN1A—urinary bladder cancer	7.4e-05	0.00109	CbGpPWpGaD
Fludarabine—Dysphagia—Epirubicin—urinary bladder cancer	7.4e-05	0.000746	CcSEcCtD
Fludarabine—Neutropenia—Methotrexate—urinary bladder cancer	7.39e-05	0.000745	CcSEcCtD
Fludarabine—Dysuria—Methotrexate—urinary bladder cancer	7.39e-05	0.000745	CcSEcCtD
Fludarabine—Pruritus—Thiotepa—urinary bladder cancer	7.39e-05	0.000745	CcSEcCtD
Fludarabine—Pain—Fluorouracil—urinary bladder cancer	7.39e-05	0.000745	CcSEcCtD
Fludarabine—Dehydration—Doxorubicin—urinary bladder cancer	7.37e-05	0.000743	CcSEcCtD
Fludarabine—Paraesthesia—Cisplatin—urinary bladder cancer	7.36e-05	0.000742	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—urinary bladder cancer	7.35e-05	0.00109	CbGpPWpGaD
Fludarabine—Thrombocytopenia—Etoposide—urinary bladder cancer	7.35e-05	0.000741	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	7.35e-05	0.000741	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	7.32e-05	0.00108	CbGpPWpGaD
Fludarabine—Liver function test abnormal—Doxorubicin—urinary bladder cancer	7.31e-05	0.000737	CcSEcCtD
Fludarabine—Dyspnoea—Cisplatin—urinary bladder cancer	7.31e-05	0.000736	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	7.29e-05	0.00108	CbGpPWpGaD
Fludarabine—Hyperhidrosis—Etoposide—urinary bladder cancer	7.26e-05	0.000732	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	7.26e-05	0.00107	CbGpPWpGaD
Fludarabine—Feeling abnormal—Gemcitabine—urinary bladder cancer	7.24e-05	0.00073	CcSEcCtD
Fludarabine—Angina pectoris—Epirubicin—urinary bladder cancer	7.21e-05	0.000727	CcSEcCtD
Fludarabine—Anorexia—Etoposide—urinary bladder cancer	7.16e-05	0.000721	CcSEcCtD
Fludarabine—Diarrhoea—Thiotepa—urinary bladder cancer	7.15e-05	0.000721	CcSEcCtD
Fludarabine—DCK—Metabolism—CYP4B1—urinary bladder cancer	7.14e-05	0.00105	CbGpPWpGaD
Fludarabine—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	7.13e-05	0.000719	CcSEcCtD
Fludarabine—POLA1—G1/S Transition—CDKN1A—urinary bladder cancer	7.13e-05	0.00105	CbGpPWpGaD
Fludarabine—Decreased appetite—Cisplatin—urinary bladder cancer	7.12e-05	0.000718	CcSEcCtD
Fludarabine—Feeling abnormal—Fluorouracil—urinary bladder cancer	7.12e-05	0.000718	CcSEcCtD
Fludarabine—Bronchitis—Epirubicin—urinary bladder cancer	7.12e-05	0.000717	CcSEcCtD
Fludarabine—Pneumonia—Methotrexate—urinary bladder cancer	7.09e-05	0.000715	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—urinary bladder cancer	7.08e-05	0.00105	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	7.07e-05	0.000713	CcSEcCtD
Fludarabine—Pancytopenia—Epirubicin—urinary bladder cancer	7.03e-05	0.000708	CcSEcCtD
Fludarabine—Pain—Cisplatin—urinary bladder cancer	7.01e-05	0.000706	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	6.99e-05	0.000705	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—RRM2—urinary bladder cancer	6.99e-05	0.00103	CbGpPWpGaD
Fludarabine—Body temperature increased—Gemcitabine—urinary bladder cancer	6.95e-05	0.000701	CcSEcCtD
Fludarabine—Renal failure—Methotrexate—urinary bladder cancer	6.93e-05	0.000699	CcSEcCtD
Fludarabine—Dysuria—Epirubicin—urinary bladder cancer	6.92e-05	0.000698	CcSEcCtD
Fludarabine—Neutropenia—Epirubicin—urinary bladder cancer	6.92e-05	0.000698	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	6.88e-05	0.000693	CcSEcCtD
Fludarabine—Stomatitis—Methotrexate—urinary bladder cancer	6.87e-05	0.000693	CcSEcCtD
Fludarabine—Dysphagia—Doxorubicin—urinary bladder cancer	6.85e-05	0.00069	CcSEcCtD
Fludarabine—Body temperature increased—Fluorouracil—urinary bladder cancer	6.83e-05	0.000689	CcSEcCtD
Fludarabine—RRM1—Metabolism—TYMP—urinary bladder cancer	6.83e-05	0.00101	CbGpPWpGaD
Fludarabine—Feeling abnormal—Cisplatin—urinary bladder cancer	6.75e-05	0.000681	CcSEcCtD
Fludarabine—DCK—Metabolism—SLC19A1—urinary bladder cancer	6.75e-05	0.000996	CbGpPWpGaD
Fludarabine—Paraesthesia—Etoposide—urinary bladder cancer	6.74e-05	0.00068	CcSEcCtD
Fludarabine—Haematuria—Methotrexate—urinary bladder cancer	6.72e-05	0.000678	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	6.7e-05	0.00099	CbGpPWpGaD
Fludarabine—Dyspnoea—Etoposide—urinary bladder cancer	6.69e-05	0.000675	CcSEcCtD
Fludarabine—POLA1—S Phase—CCND1—urinary bladder cancer	6.69e-05	0.000988	CbGpPWpGaD
Fludarabine—Hyperglycaemia—Epirubicin—urinary bladder cancer	6.68e-05	0.000673	CcSEcCtD
Fludarabine—Angina pectoris—Doxorubicin—urinary bladder cancer	6.67e-05	0.000672	CcSEcCtD
Fludarabine—Epistaxis—Methotrexate—urinary bladder cancer	6.65e-05	0.00067	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—SMC1A—urinary bladder cancer	6.65e-05	0.000981	CbGpPWpGaD
Fludarabine—Vomiting—Thiotepa—urinary bladder cancer	6.64e-05	0.00067	CcSEcCtD
Fludarabine—Pneumonia—Epirubicin—urinary bladder cancer	6.64e-05	0.000669	CcSEcCtD
Fludarabine—Rash—Thiotepa—urinary bladder cancer	6.59e-05	0.000664	CcSEcCtD
Fludarabine—Bronchitis—Doxorubicin—urinary bladder cancer	6.58e-05	0.000664	CcSEcCtD
Fludarabine—Dermatitis—Thiotepa—urinary bladder cancer	6.58e-05	0.000664	CcSEcCtD
Fludarabine—DCK—Metabolism—PRSS3—urinary bladder cancer	6.57e-05	0.000971	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	6.56e-05	0.000968	CbGpPWpGaD
Fludarabine—Headache—Thiotepa—urinary bladder cancer	6.55e-05	0.00066	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	6.54e-05	0.000659	CcSEcCtD
Fludarabine—Decreased appetite—Etoposide—urinary bladder cancer	6.53e-05	0.000658	CcSEcCtD
Fludarabine—Pancytopenia—Doxorubicin—urinary bladder cancer	6.5e-05	0.000655	CcSEcCtD
Fludarabine—Renal failure—Epirubicin—urinary bladder cancer	6.49e-05	0.000654	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	6.48e-05	0.000653	CcSEcCtD
Fludarabine—Body temperature increased—Cisplatin—urinary bladder cancer	6.48e-05	0.000653	CcSEcCtD
Fludarabine—POLA1—S Phase—CDKN1A—urinary bladder cancer	6.47e-05	0.000956	CbGpPWpGaD
Fludarabine—Fatigue—Etoposide—urinary bladder cancer	6.47e-05	0.000652	CcSEcCtD
Fludarabine—Neuropathy peripheral—Epirubicin—urinary bladder cancer	6.47e-05	0.000652	CcSEcCtD
Fludarabine—Stomatitis—Epirubicin—urinary bladder cancer	6.43e-05	0.000648	CcSEcCtD
Fludarabine—Pain—Etoposide—urinary bladder cancer	6.42e-05	0.000647	CcSEcCtD
Fludarabine—Constipation—Etoposide—urinary bladder cancer	6.42e-05	0.000647	CcSEcCtD
Fludarabine—Urinary tract infection—Epirubicin—urinary bladder cancer	6.41e-05	0.000647	CcSEcCtD
Fludarabine—Dysuria—Doxorubicin—urinary bladder cancer	6.4e-05	0.000645	CcSEcCtD
Fludarabine—Neutropenia—Doxorubicin—urinary bladder cancer	6.4e-05	0.000645	CcSEcCtD
Fludarabine—Hypersensitivity—Fluorouracil—urinary bladder cancer	6.37e-05	0.000642	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	6.36e-05	0.000641	CcSEcCtD
Fludarabine—Haemoglobin—Methotrexate—urinary bladder cancer	6.36e-05	0.000641	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	6.36e-05	0.000939	CbGpPWpGaD
Fludarabine—Haemorrhage—Methotrexate—urinary bladder cancer	6.33e-05	0.000638	CcSEcCtD
Fludarabine—Asthenia—Gemcitabine—urinary bladder cancer	6.31e-05	0.000636	CcSEcCtD
Fludarabine—Haematuria—Epirubicin—urinary bladder cancer	6.29e-05	0.000634	CcSEcCtD
Fludarabine—Pharyngitis—Methotrexate—urinary bladder cancer	6.28e-05	0.000633	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	6.28e-05	0.000928	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	6.24e-05	0.000922	CbGpPWpGaD
Fludarabine—Epistaxis—Epirubicin—urinary bladder cancer	6.22e-05	0.000627	CcSEcCtD
Fludarabine—Pruritus—Gemcitabine—urinary bladder cancer	6.22e-05	0.000627	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CCND1—urinary bladder cancer	6.21e-05	0.000917	CbGpPWpGaD
Fludarabine—Nausea—Thiotepa—urinary bladder cancer	6.21e-05	0.000626	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	6.19e-05	0.000914	CbGpPWpGaD
Fludarabine—Sinusitis—Epirubicin—urinary bladder cancer	6.19e-05	0.000624	CcSEcCtD
Fludarabine—Feeling abnormal—Etoposide—urinary bladder cancer	6.19e-05	0.000624	CcSEcCtD
Fludarabine—Hyperglycaemia—Doxorubicin—urinary bladder cancer	6.18e-05	0.000623	CcSEcCtD
Fludarabine—RRM1—Metabolism—NAT2—urinary bladder cancer	6.18e-05	0.000912	CbGpPWpGaD
Fludarabine—Pneumonia—Doxorubicin—urinary bladder cancer	6.14e-05	0.000619	CcSEcCtD
Fludarabine—Pruritus—Fluorouracil—urinary bladder cancer	6.12e-05	0.000616	CcSEcCtD
Fludarabine—Visual impairment—Methotrexate—urinary bladder cancer	6.1e-05	0.000615	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	6.05e-05	0.00061	CcSEcCtD
Fludarabine—Hypersensitivity—Cisplatin—urinary bladder cancer	6.04e-05	0.000609	CcSEcCtD
Fludarabine—Diarrhoea—Gemcitabine—urinary bladder cancer	6.02e-05	0.000606	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—urinary bladder cancer	6.01e-05	0.000887	CbGpPWpGaD
Fludarabine—Renal failure—Doxorubicin—urinary bladder cancer	6e-05	0.000605	CcSEcCtD
Fludarabine—Erythema multiforme—Methotrexate—urinary bladder cancer	5.98e-05	0.000603	CcSEcCtD
Fludarabine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	5.98e-05	0.000603	CcSEcCtD
Fludarabine—Haemoglobin—Epirubicin—urinary bladder cancer	5.95e-05	0.0006	CcSEcCtD
Fludarabine—Stomatitis—Doxorubicin—urinary bladder cancer	5.95e-05	0.0006	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—SMC1A—urinary bladder cancer	5.94e-05	0.000878	CbGpPWpGaD
Fludarabine—Body temperature increased—Etoposide—urinary bladder cancer	5.93e-05	0.000598	CcSEcCtD
Fludarabine—Urinary tract infection—Doxorubicin—urinary bladder cancer	5.93e-05	0.000598	CcSEcCtD
Fludarabine—Haemorrhage—Epirubicin—urinary bladder cancer	5.92e-05	0.000597	CcSEcCtD
Fludarabine—Diarrhoea—Fluorouracil—urinary bladder cancer	5.91e-05	0.000596	CcSEcCtD
Fludarabine—POLA1—G1/S Transition—MYC—urinary bladder cancer	5.91e-05	0.000873	CbGpPWpGaD
Fludarabine—Hypoaesthesia—Epirubicin—urinary bladder cancer	5.89e-05	0.000594	CcSEcCtD
Fludarabine—Asthenia—Cisplatin—urinary bladder cancer	5.88e-05	0.000593	CcSEcCtD
Fludarabine—Pharyngitis—Epirubicin—urinary bladder cancer	5.88e-05	0.000593	CcSEcCtD
Fludarabine—Haematuria—Doxorubicin—urinary bladder cancer	5.82e-05	0.000587	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—urinary bladder cancer	5.82e-05	0.000859	CbGpPWpGaD
Fludarabine—Epistaxis—Doxorubicin—urinary bladder cancer	5.76e-05	0.00058	CcSEcCtD
Fludarabine—Sinusitis—Doxorubicin—urinary bladder cancer	5.73e-05	0.000577	CcSEcCtD
Fludarabine—Visual impairment—Epirubicin—urinary bladder cancer	5.71e-05	0.000575	CcSEcCtD
Fludarabine—Chills—Methotrexate—urinary bladder cancer	5.68e-05	0.000572	CcSEcCtD
Fludarabine—Diarrhoea—Cisplatin—urinary bladder cancer	5.61e-05	0.000565	CcSEcCtD
Fludarabine—Erythema multiforme—Epirubicin—urinary bladder cancer	5.6e-05	0.000565	CcSEcCtD
Fludarabine—Alopecia—Methotrexate—urinary bladder cancer	5.59e-05	0.000564	CcSEcCtD
Fludarabine—Vomiting—Gemcitabine—urinary bladder cancer	5.59e-05	0.000563	CcSEcCtD
Fludarabine—Rash—Gemcitabine—urinary bladder cancer	5.54e-05	0.000559	CcSEcCtD
Fludarabine—Dermatitis—Gemcitabine—urinary bladder cancer	5.54e-05	0.000558	CcSEcCtD
Fludarabine—Hypersensitivity—Etoposide—urinary bladder cancer	5.53e-05	0.000558	CcSEcCtD
Fludarabine—Malnutrition—Methotrexate—urinary bladder cancer	5.51e-05	0.000555	CcSEcCtD
Fludarabine—Haemoglobin—Doxorubicin—urinary bladder cancer	5.51e-05	0.000555	CcSEcCtD
Fludarabine—Headache—Gemcitabine—urinary bladder cancer	5.51e-05	0.000555	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	5.5e-05	0.000813	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.5e-05	0.000812	CbGpPWpGaD
Fludarabine—Vomiting—Fluorouracil—urinary bladder cancer	5.5e-05	0.000554	CcSEcCtD
Fludarabine—Haemorrhage—Doxorubicin—urinary bladder cancer	5.48e-05	0.000552	CcSEcCtD
Fludarabine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	5.45e-05	0.00055	CcSEcCtD
Fludarabine—Rash—Fluorouracil—urinary bladder cancer	5.45e-05	0.000549	CcSEcCtD
Fludarabine—Dermatitis—Fluorouracil—urinary bladder cancer	5.45e-05	0.000549	CcSEcCtD
Fludarabine—Pharyngitis—Doxorubicin—urinary bladder cancer	5.44e-05	0.000548	CcSEcCtD
Fludarabine—Headache—Fluorouracil—urinary bladder cancer	5.42e-05	0.000546	CcSEcCtD
Fludarabine—Asthenia—Etoposide—urinary bladder cancer	5.39e-05	0.000543	CcSEcCtD
Fludarabine—POLA1—S Phase—MYC—urinary bladder cancer	5.37e-05	0.000793	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—RRM2—urinary bladder cancer	5.33e-05	0.000787	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	5.33e-05	0.000787	CbGpPWpGaD
Fludarabine—Chills—Epirubicin—urinary bladder cancer	5.31e-05	0.000536	CcSEcCtD
Fludarabine—Pruritus—Etoposide—urinary bladder cancer	5.31e-05	0.000535	CcSEcCtD
Fludarabine—Arrhythmia—Epirubicin—urinary bladder cancer	5.29e-05	0.000533	CcSEcCtD
Fludarabine—Visual impairment—Doxorubicin—urinary bladder cancer	5.28e-05	0.000532	CcSEcCtD
Fludarabine—DCK—Metabolism—TYMP—urinary bladder cancer	5.26e-05	0.000776	CbGpPWpGaD
Fludarabine—Alopecia—Epirubicin—urinary bladder cancer	5.23e-05	0.000528	CcSEcCtD
Fludarabine—Nausea—Gemcitabine—urinary bladder cancer	5.22e-05	0.000526	CcSEcCtD
Fludarabine—Vomiting—Cisplatin—urinary bladder cancer	5.21e-05	0.000525	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	5.21e-05	0.000769	CbGpPWpGaD
Fludarabine—Erythema multiforme—Doxorubicin—urinary bladder cancer	5.18e-05	0.000522	CcSEcCtD
Fludarabine—Rash—Cisplatin—urinary bladder cancer	5.17e-05	0.000521	CcSEcCtD
Fludarabine—Dermatitis—Cisplatin—urinary bladder cancer	5.16e-05	0.00052	CcSEcCtD
Fludarabine—Malnutrition—Epirubicin—urinary bladder cancer	5.16e-05	0.00052	CcSEcCtD
Fludarabine—Diarrhoea—Etoposide—urinary bladder cancer	5.14e-05	0.000518	CcSEcCtD
Fludarabine—Nausea—Fluorouracil—urinary bladder cancer	5.13e-05	0.000518	CcSEcCtD
Fludarabine—Ill-defined disorder—Methotrexate—urinary bladder cancer	5.11e-05	0.000515	CcSEcCtD
Fludarabine—Anaemia—Methotrexate—urinary bladder cancer	5.09e-05	0.000513	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—MYC—urinary bladder cancer	4.98e-05	0.000736	CbGpPWpGaD
Fludarabine—Malaise—Methotrexate—urinary bladder cancer	4.97e-05	0.000501	CcSEcCtD
Fludarabine—RRM1—Metabolism—ENO2—urinary bladder cancer	4.94e-05	0.000729	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HPGDS—urinary bladder cancer	4.94e-05	0.000729	CbGpPWpGaD
Fludarabine—Leukopenia—Methotrexate—urinary bladder cancer	4.93e-05	0.000497	CcSEcCtD
Fludarabine—Chills—Doxorubicin—urinary bladder cancer	4.92e-05	0.000496	CcSEcCtD
Fludarabine—Arrhythmia—Doxorubicin—urinary bladder cancer	4.9e-05	0.000494	CcSEcCtD
Fludarabine—Nausea—Cisplatin—urinary bladder cancer	4.87e-05	0.000491	CcSEcCtD
Fludarabine—Alopecia—Doxorubicin—urinary bladder cancer	4.84e-05	0.000488	CcSEcCtD
Fludarabine—Cough—Methotrexate—urinary bladder cancer	4.81e-05	0.000485	CcSEcCtD
Fludarabine—RRM1—Metabolism—GSTT1—urinary bladder cancer	4.79e-05	0.000707	CbGpPWpGaD
Fludarabine—Ill-defined disorder—Epirubicin—urinary bladder cancer	4.78e-05	0.000482	CcSEcCtD
Fludarabine—Convulsion—Methotrexate—urinary bladder cancer	4.77e-05	0.000481	CcSEcCtD
Fludarabine—Vomiting—Etoposide—urinary bladder cancer	4.77e-05	0.000481	CcSEcCtD
Fludarabine—Malnutrition—Doxorubicin—urinary bladder cancer	4.77e-05	0.000481	CcSEcCtD
Fludarabine—Anaemia—Epirubicin—urinary bladder cancer	4.77e-05	0.00048	CcSEcCtD
Fludarabine—DCK—Metabolism—NAT2—urinary bladder cancer	4.75e-05	0.000702	CbGpPWpGaD
Fludarabine—Agitation—Epirubicin—urinary bladder cancer	4.74e-05	0.000478	CcSEcCtD
Fludarabine—Rash—Etoposide—urinary bladder cancer	4.73e-05	0.000477	CcSEcCtD
Fludarabine—Dermatitis—Etoposide—urinary bladder cancer	4.73e-05	0.000477	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	4.71e-05	0.000695	CbGpPWpGaD
Fludarabine—Headache—Etoposide—urinary bladder cancer	4.7e-05	0.000474	CcSEcCtD
Fludarabine—Myalgia—Methotrexate—urinary bladder cancer	4.69e-05	0.000473	CcSEcCtD
Fludarabine—Arthralgia—Methotrexate—urinary bladder cancer	4.69e-05	0.000473	CcSEcCtD
Fludarabine—Malaise—Epirubicin—urinary bladder cancer	4.65e-05	0.000469	CcSEcCtD
Fludarabine—Discomfort—Methotrexate—urinary bladder cancer	4.63e-05	0.000467	CcSEcCtD
Fludarabine—Leukopenia—Epirubicin—urinary bladder cancer	4.62e-05	0.000465	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—CCNE1—urinary bladder cancer	4.61e-05	0.00068	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	4.55e-05	0.000672	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	4.54e-05	0.000671	CbGpPWpGaD
Fludarabine—Confusional state—Methotrexate—urinary bladder cancer	4.53e-05	0.000457	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—TYMS—urinary bladder cancer	4.52e-05	0.000668	CbGpPWpGaD
Fludarabine—Cough—Epirubicin—urinary bladder cancer	4.5e-05	0.000454	CcSEcCtD
Fludarabine—Anaphylactic shock—Methotrexate—urinary bladder cancer	4.5e-05	0.000453	CcSEcCtD
Fludarabine—Convulsion—Epirubicin—urinary bladder cancer	4.47e-05	0.00045	CcSEcCtD
Fludarabine—Infection—Methotrexate—urinary bladder cancer	4.47e-05	0.00045	CcSEcCtD
Fludarabine—Nausea—Etoposide—urinary bladder cancer	4.46e-05	0.00045	CcSEcCtD
Fludarabine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	4.43e-05	0.000446	CcSEcCtD
Fludarabine—Nervous system disorder—Methotrexate—urinary bladder cancer	4.41e-05	0.000445	CcSEcCtD
Fludarabine—Anaemia—Doxorubicin—urinary bladder cancer	4.41e-05	0.000445	CcSEcCtD
Fludarabine—Thrombocytopenia—Methotrexate—urinary bladder cancer	4.4e-05	0.000444	CcSEcCtD
Fludarabine—Myalgia—Epirubicin—urinary bladder cancer	4.39e-05	0.000443	CcSEcCtD
Fludarabine—Arthralgia—Epirubicin—urinary bladder cancer	4.39e-05	0.000443	CcSEcCtD
Fludarabine—Agitation—Doxorubicin—urinary bladder cancer	4.38e-05	0.000442	CcSEcCtD
Fludarabine—Hyperhidrosis—Methotrexate—urinary bladder cancer	4.35e-05	0.000438	CcSEcCtD
Fludarabine—Discomfort—Epirubicin—urinary bladder cancer	4.34e-05	0.000437	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	4.33e-05	0.00064	CbGpPWpGaD
Fludarabine—Malaise—Doxorubicin—urinary bladder cancer	4.3e-05	0.000434	CcSEcCtD
Fludarabine—Anorexia—Methotrexate—urinary bladder cancer	4.29e-05	0.000432	CcSEcCtD
Fludarabine—Leukopenia—Doxorubicin—urinary bladder cancer	4.27e-05	0.00043	CcSEcCtD
Fludarabine—Confusional state—Epirubicin—urinary bladder cancer	4.24e-05	0.000428	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	4.21e-05	0.000622	CbGpPWpGaD
Fludarabine—Anaphylactic shock—Epirubicin—urinary bladder cancer	4.21e-05	0.000424	CcSEcCtD
Fludarabine—Oedema—Epirubicin—urinary bladder cancer	4.21e-05	0.000424	CcSEcCtD
Fludarabine—Infection—Epirubicin—urinary bladder cancer	4.18e-05	0.000421	CcSEcCtD
Fludarabine—Cough—Doxorubicin—urinary bladder cancer	4.16e-05	0.00042	CcSEcCtD
Fludarabine—Convulsion—Doxorubicin—urinary bladder cancer	4.13e-05	0.000417	CcSEcCtD
Fludarabine—Nervous system disorder—Epirubicin—urinary bladder cancer	4.13e-05	0.000416	CcSEcCtD
Fludarabine—Thrombocytopenia—Epirubicin—urinary bladder cancer	4.12e-05	0.000415	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—CCNE1—urinary bladder cancer	4.12e-05	0.000608	CbGpPWpGaD
Fludarabine—DCK—Metabolism—RRM2—urinary bladder cancer	4.1e-05	0.000606	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—RB1—urinary bladder cancer	4.1e-05	0.000606	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.1e-05	0.000606	CbGpPWpGaD
Fludarabine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	4.1e-05	0.000413	CcSEcCtD
Fludarabine—Hyperhidrosis—Epirubicin—urinary bladder cancer	4.07e-05	0.00041	CcSEcCtD
Fludarabine—Arthralgia—Doxorubicin—urinary bladder cancer	4.06e-05	0.000409	CcSEcCtD
Fludarabine—Myalgia—Doxorubicin—urinary bladder cancer	4.06e-05	0.000409	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—TYMS—urinary bladder cancer	4.05e-05	0.000597	CbGpPWpGaD
Fludarabine—Paraesthesia—Methotrexate—urinary bladder cancer	4.04e-05	0.000407	CcSEcCtD
Fludarabine—Discomfort—Doxorubicin—urinary bladder cancer	4.01e-05	0.000405	CcSEcCtD
Fludarabine—Anorexia—Epirubicin—urinary bladder cancer	4.01e-05	0.000404	CcSEcCtD
Fludarabine—Dyspnoea—Methotrexate—urinary bladder cancer	4.01e-05	0.000404	CcSEcCtD
Fludarabine—RRM1—Metabolism—NQO1—urinary bladder cancer	3.98e-05	0.000588	CbGpPWpGaD
Fludarabine—Dyspepsia—Methotrexate—urinary bladder cancer	3.96e-05	0.000399	CcSEcCtD
Fludarabine—Confusional state—Doxorubicin—urinary bladder cancer	3.93e-05	0.000396	CcSEcCtD
Fludarabine—Decreased appetite—Methotrexate—urinary bladder cancer	3.91e-05	0.000394	CcSEcCtD
Fludarabine—Oedema—Doxorubicin—urinary bladder cancer	3.89e-05	0.000393	CcSEcCtD
Fludarabine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	3.89e-05	0.000393	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	3.88e-05	0.000391	CcSEcCtD
Fludarabine—Fatigue—Methotrexate—urinary bladder cancer	3.88e-05	0.000391	CcSEcCtD
Fludarabine—Infection—Doxorubicin—urinary bladder cancer	3.87e-05	0.00039	CcSEcCtD
Fludarabine—Pain—Methotrexate—urinary bladder cancer	3.85e-05	0.000388	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	3.83e-05	0.000386	CcSEcCtD
Fludarabine—Nervous system disorder—Doxorubicin—urinary bladder cancer	3.82e-05	0.000385	CcSEcCtD
Fludarabine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	3.81e-05	0.000384	CcSEcCtD
Fludarabine—DCK—Metabolism—ENO2—urinary bladder cancer	3.8e-05	0.000561	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HPGDS—urinary bladder cancer	3.8e-05	0.000561	CbGpPWpGaD
Fludarabine—Paraesthesia—Epirubicin—urinary bladder cancer	3.78e-05	0.000381	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.77e-05	0.000557	CbGpPWpGaD
Fludarabine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	3.76e-05	0.000379	CcSEcCtD
Fludarabine—Dyspnoea—Epirubicin—urinary bladder cancer	3.75e-05	0.000378	CcSEcCtD
Fludarabine—Anorexia—Doxorubicin—urinary bladder cancer	3.71e-05	0.000374	CcSEcCtD
Fludarabine—Feeling abnormal—Methotrexate—urinary bladder cancer	3.71e-05	0.000374	CcSEcCtD
Fludarabine—Dyspepsia—Epirubicin—urinary bladder cancer	3.7e-05	0.000373	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.69e-05	0.000545	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTT1—urinary bladder cancer	3.69e-05	0.000544	CbGpPWpGaD
Fludarabine—Decreased appetite—Epirubicin—urinary bladder cancer	3.66e-05	0.000369	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	3.63e-05	0.000366	CcSEcCtD
Fludarabine—Fatigue—Epirubicin—urinary bladder cancer	3.63e-05	0.000366	CcSEcCtD
Fludarabine—Constipation—Epirubicin—urinary bladder cancer	3.6e-05	0.000363	CcSEcCtD
Fludarabine—Pain—Epirubicin—urinary bladder cancer	3.6e-05	0.000363	CcSEcCtD
Fludarabine—Body temperature increased—Methotrexate—urinary bladder cancer	3.55e-05	0.000358	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	3.55e-05	0.000358	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDK4—urinary bladder cancer	3.53e-05	0.000521	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—TERT—urinary bladder cancer	3.52e-05	0.00052	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.52e-05	0.000519	CbGpPWpGaD
Fludarabine—Paraesthesia—Doxorubicin—urinary bladder cancer	3.5e-05	0.000352	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.49e-05	0.000515	CbGpPWpGaD
Fludarabine—Dyspnoea—Doxorubicin—urinary bladder cancer	3.47e-05	0.00035	CcSEcCtD
Fludarabine—Feeling abnormal—Epirubicin—urinary bladder cancer	3.47e-05	0.00035	CcSEcCtD
Fludarabine—Dyspepsia—Doxorubicin—urinary bladder cancer	3.43e-05	0.000346	CcSEcCtD
Fludarabine—Decreased appetite—Doxorubicin—urinary bladder cancer	3.38e-05	0.000341	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	3.36e-05	0.000339	CcSEcCtD
Fludarabine—Fatigue—Doxorubicin—urinary bladder cancer	3.36e-05	0.000338	CcSEcCtD
Fludarabine—Constipation—Doxorubicin—urinary bladder cancer	3.33e-05	0.000336	CcSEcCtD
Fludarabine—Pain—Doxorubicin—urinary bladder cancer	3.33e-05	0.000336	CcSEcCtD
Fludarabine—Body temperature increased—Epirubicin—urinary bladder cancer	3.33e-05	0.000335	CcSEcCtD
Fludarabine—RRM1—Metabolism—GSTP1—urinary bladder cancer	3.32e-05	0.00049	CbGpPWpGaD
Fludarabine—Hypersensitivity—Methotrexate—urinary bladder cancer	3.31e-05	0.000334	CcSEcCtD
Fludarabine—Asthenia—Methotrexate—urinary bladder cancer	3.23e-05	0.000325	CcSEcCtD
Fludarabine—Feeling abnormal—Doxorubicin—urinary bladder cancer	3.21e-05	0.000323	CcSEcCtD
Fludarabine—Pruritus—Methotrexate—urinary bladder cancer	3.18e-05	0.000321	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—ATM—urinary bladder cancer	3.17e-05	0.000468	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDK4—urinary bladder cancer	3.15e-05	0.000466	CbGpPWpGaD
Fludarabine—Hypersensitivity—Epirubicin—urinary bladder cancer	3.1e-05	0.000313	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.1e-05	0.000458	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—TYMS—urinary bladder cancer	3.09e-05	0.000456	CbGpPWpGaD
Fludarabine—Body temperature increased—Doxorubicin—urinary bladder cancer	3.08e-05	0.00031	CcSEcCtD
Fludarabine—Diarrhoea—Methotrexate—urinary bladder cancer	3.08e-05	0.00031	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—RB1—urinary bladder cancer	3.07e-05	0.000453	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NQO1—urinary bladder cancer	3.06e-05	0.000452	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NCOR1—urinary bladder cancer	3.05e-05	0.00045	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTM1—urinary bladder cancer	3.05e-05	0.00045	CbGpPWpGaD
Fludarabine—Asthenia—Epirubicin—urinary bladder cancer	3.02e-05	0.000304	CcSEcCtD
Fludarabine—Pruritus—Epirubicin—urinary bladder cancer	2.98e-05	0.0003	CcSEcCtD
Fludarabine—RRM1—Metabolism—GPX1—urinary bladder cancer	2.92e-05	0.000431	CbGpPWpGaD
Fludarabine—Diarrhoea—Epirubicin—urinary bladder cancer	2.88e-05	0.00029	CcSEcCtD
Fludarabine—Hypersensitivity—Doxorubicin—urinary bladder cancer	2.87e-05	0.000289	CcSEcCtD
Fludarabine—RRM1—Metabolism—ERCC2—urinary bladder cancer	2.87e-05	0.000423	CbGpPWpGaD
Fludarabine—Vomiting—Methotrexate—urinary bladder cancer	2.86e-05	0.000288	CcSEcCtD
Fludarabine—Rash—Methotrexate—urinary bladder cancer	2.84e-05	0.000286	CcSEcCtD
Fludarabine—Dermatitis—Methotrexate—urinary bladder cancer	2.83e-05	0.000286	CcSEcCtD
Fludarabine—Headache—Methotrexate—urinary bladder cancer	2.82e-05	0.000284	CcSEcCtD
Fludarabine—Asthenia—Doxorubicin—urinary bladder cancer	2.79e-05	0.000282	CcSEcCtD
Fludarabine—Pruritus—Doxorubicin—urinary bladder cancer	2.75e-05	0.000278	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—RB1—urinary bladder cancer	2.74e-05	0.000405	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	2.7e-05	0.000398	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—MTHFR—urinary bladder cancer	2.7e-05	0.000398	CbGpPWpGaD
Fludarabine—Vomiting—Epirubicin—urinary bladder cancer	2.68e-05	0.00027	CcSEcCtD
Fludarabine—Nausea—Methotrexate—urinary bladder cancer	2.67e-05	0.000269	CcSEcCtD
Fludarabine—Diarrhoea—Doxorubicin—urinary bladder cancer	2.66e-05	0.000269	CcSEcCtD
Fludarabine—Rash—Epirubicin—urinary bladder cancer	2.65e-05	0.000267	CcSEcCtD
Fludarabine—Dermatitis—Epirubicin—urinary bladder cancer	2.65e-05	0.000267	CcSEcCtD
Fludarabine—Headache—Epirubicin—urinary bladder cancer	2.64e-05	0.000266	CcSEcCtD
Fludarabine—DCK—Metabolism—GSTP1—urinary bladder cancer	2.55e-05	0.000377	CbGpPWpGaD
Fludarabine—Nausea—Epirubicin—urinary bladder cancer	2.5e-05	0.000252	CcSEcCtD
Fludarabine—Vomiting—Doxorubicin—urinary bladder cancer	2.48e-05	0.00025	CcSEcCtD
Fludarabine—Rash—Doxorubicin—urinary bladder cancer	2.46e-05	0.000247	CcSEcCtD
Fludarabine—Dermatitis—Doxorubicin—urinary bladder cancer	2.45e-05	0.000247	CcSEcCtD
Fludarabine—Headache—Doxorubicin—urinary bladder cancer	2.44e-05	0.000246	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—CDKN2A—urinary bladder cancer	2.41e-05	0.000356	CbGpPWpGaD
Fludarabine—DCK—Metabolism—TYMS—urinary bladder cancer	2.37e-05	0.000351	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NCOR1—urinary bladder cancer	2.35e-05	0.000347	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTM1—urinary bladder cancer	2.35e-05	0.000347	CbGpPWpGaD
Fludarabine—Nausea—Doxorubicin—urinary bladder cancer	2.31e-05	0.000233	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	2.28e-05	0.000336	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GPX1—urinary bladder cancer	2.25e-05	0.000332	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ERCC2—urinary bladder cancer	2.21e-05	0.000326	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	2.2e-05	0.000325	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PPARG—urinary bladder cancer	2.19e-05	0.000323	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CREBBP—urinary bladder cancer	2.1e-05	0.00031	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—EP300—urinary bladder cancer	2.1e-05	0.00031	CbGpPWpGaD
Fludarabine—DCK—Metabolism—MTHFR—urinary bladder cancer	2.07e-05	0.000306	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CCND1—urinary bladder cancer	2.04e-05	0.000301	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN1A—urinary bladder cancer	1.97e-05	0.000291	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—EP300—urinary bladder cancer	1.88e-05	0.000277	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MYC—urinary bladder cancer	1.83e-05	0.00027	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PTGS2—urinary bladder cancer	1.72e-05	0.000254	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PPARG—urinary bladder cancer	1.68e-05	0.000248	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MYC—urinary bladder cancer	1.63e-05	0.000241	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CREBBP—urinary bladder cancer	1.62e-05	0.000239	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PTEN—urinary bladder cancer	1.5e-05	0.000221	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—EP300—urinary bladder cancer	1.43e-05	0.000211	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—TP53—urinary bladder cancer	1.34e-05	0.000198	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PTGS2—urinary bladder cancer	1.32e-05	0.000195	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PTEN—urinary bladder cancer	1.15e-05	0.00017	CbGpPWpGaD
Fludarabine—DCK—Metabolism—EP300—urinary bladder cancer	1.1e-05	0.000163	CbGpPWpGaD
